Complement modulates the cutaneous microbiome and inflammatory milieu

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 37, 2013, Pages 15061-15066

  Chehoud, Christel ^a   Rafail, Stavros ^b   Tyldsley, Amanda S ^a   Seykora, John T ^a   Lambris, John D ^b   Grice, Elizabeth A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; RNA 16S;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMMENSAL; CONTROLLED STUDY; GENE EXPRESSION; HOST PATHOGEN INTERACTION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FLORA;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; COMPLEMENT SYSTEM PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICROBIOTA; MOLECULAR SEQUENCE DATA; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, PATTERN RECOGNITION; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SIGNAL TRANSDUCTION; SKIN;

EID: 84883759310     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1307855110     Document Type: Article

References (42)

1. Naik S, et al. (2012) Compartmentalized control of skin immunity by resident commensals. Science 337(6098):1115-1119.
2. Lai Y, et al. (2009) Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 15(12):1377-1382.
3. Grice EA, Segre JA (2011) The skin microbiome. Nat Rev Microbiol 9(4):244-253.
4. Costello EK, et al. (2009) Bacterial community variation in human body habitats across space and time. Science 326(5960):1694-1697.
5. Gao Z, Tseng CH, Pei Z, Blaser MJ (2007) Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci USA 104(8):2927-2932. (Pubitemid 46327980)
6. Grice EA, et al. (2008) A diversity profile of the human skin microbiota. Genome Res 18(7):1043-1050. (Pubitemid 351931155)
7. Grice EA, et al. (2009) Topographical and temporal diversity of the human skin microbiome. Science 324(5931):1190-1192.
8. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486(7402):207-214.
9. Blaser MJ, et al. (2013) Distinct cutaneous bacterial assemblages in a sampling of South American Amerindians and US residents. ISME J 7(1):85-95.
10. Fierer N, Hamady M, Lauber CL, Knight R (2008) The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci USA 105(46):17994-17999.
11. Oh J, Conlan S, Polley EC, Segre JA, Kong HH (2012) Shifts in human skin and nares microbiota of healthy children and adults. Genome Med 4(10):77.
12. Redel H, et al. (2013) Quantitation and composition of cutaneous microbiota in diabetic and nondiabetic men. J Infect Dis 207(7):1105-1114.
13. Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: A key system for immune surveillance and homeostasis. Nat Immunol 11(9):785-797.
14. Pettigrew HD, Teuber SS, Gershwin ME (2009) Clinical significance of complement deficiencies. Ann N Y Acad Sci 1173:108-123.
15. Kotnik V (2011) Complement in skin diseases. Acta Dermatovenerol Alp Panonica Adriat 20(1):3-11.
16. Isolauri E, et al. (1997) Altered expression of IgG and complement receptors indicates a significant role of phagocytes in atopic dermatitis. J Allergy Clin Immunol 99(5):707-713. (Pubitemid 27213200)
17. Tagami H (1992) The role of complement-derived mediators in inflammatory skin diseases. Arch Dermatol Res 284(suppl 1):S2-S9.
18. Scott DG, Cunliffe WJ, Gowland G (1979) Activation of complement-a mechanism for the inflammation in acne. Br J Dermatol 101(3):315-320. (Pubitemid 10134381)
19. Hajishengallis G, Lambris JD (2010) Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31(4):154-163.
20. Köhl J (2006) Drug evaluation: The C5a receptor antagonist PMX-53. Curr Opin Mol Ther 8(6):529-538.
21. Lozupone C, Knight R (2005) UniFrac: A new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71(12):8228-8235. (Pubitemid 41803949)
22. Reinicke AT, et al. (2012) C5aR regulates intestinal microbiota composition and controls the induction of gastrointestinal allergic hypersensitivity. Immunobiology 217(11):1147.
23. Trapnell C, et al. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7(3):562-578.
24. Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336(6086):1268-1273.
25. Kong HH, et al. (2012) Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 22(5):850-859.
26. Guenther LC (1983) Inherited disorders of complement. J Am Acad Dermatol 9(6):815-839.
27. Rosenfeld SI, Kelly ME, Leddy JP (1976) Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies. J Clin Invest 57(6):1626-1634.
28. Wang X, et al. (1995) Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and compound heterozygosity in three African-American families. J Immunol 154(10):5464-5471.
29. Wang H, et al. (2006) Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 116(8):2105-2114. (Pubitemid 44162319)
30. Nomura I, et al. (2003) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: A gene microarray analysis. J Allergy Clin Immunol 112(6):1195-1202. (Pubitemid 37550015)
31. Pelletier M, et al. (2010) Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115(2):335-343.
32. Hyun YM, Lefort CT, Kim M (2009) Leukocyte integrins and their ligand interactions. Immunol Res 45(2-3):195-208.
33. Lebwohl M, et al.; Efalizumab Study Group (2003) A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med 349(21):2004-2013. (Pubitemid 37448923)
34. Harris CL, Heurich M, Rodriguez de Cordoba S, Morgan BP (2012) The complotype: Dictating risk for inflammation and infection. Trends Immunol 33(10):513-521.
35. Mrowietz U, et al. (2001) Psoriasis scales contain C5a as the predominant chemotaxin for monocyte-derived dendritic cells. Exp Dermatol 10(4):238-245. (Pubitemid 32754992)
36. Takematsu H, Ohkohchi K, Tagami H (1986) Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses. Br J Dermatol 114(1):1-6. (Pubitemid 16128756)
37. McFadden JP, Baker BS, Powles AV, Fry L (2009) Psoriasis and streptococci: The natural selection of psoriasis revisited. Br J Dermatol 160(5):929-937.
38. Grice EA, Segre JA (2012) Interaction of the microbiome with the innate immune response in chronic wounds. Adv Exp Med Biol 946:55-68.
39. Grice EA, et al. (2010) Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc Natl Acad Sci USA 107(33):14799-14804.
40. Finch AM, et al. (1999) Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J Med Chem 42(11):1965-1974. (Pubitemid 29269629)
41. Markiewski MM, et al. (2008) Modulation of the antitumor immune response by complement. Nat Immunol 9(11):1225-1235.
42. Caporaso JG, et al. (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335-336.